Skip to main content

Advertisement

Log in

Increased toxic urinary cations in males with interstitial cystitis: a possible cause of bladder symptoms

  • Original Article
  • Published:
World Journal of Urology Aims and scope Submit manuscript

Abstract

Purpose

To identify and quantify toxic urinary cations in male patients with bladder pain syndrome/interstitial cystitis versus male controls, to compare them in symptomatic patients to those significantly improved, and to evaluate cytotoxicity of these cations to cultured urothelial cells to determine whether Tamm-Horsfall protein (THP) can neutralize the cations.

Methods

Isolation of cationic fraction (CFs) was achieved by solid phase extraction on urine specimens of 51 male patients with IC and 33 male controls. C18 reverse-phase high-performance liquid chromatography was used to profile and quantify cationic metabolites. Major CF peaks were identified by liquid chromatography–tandem mass spectrometry. HTB-4 urothelial cells were used to determine the cytotoxicity of CFs, individual metabolites, and of metabolite mixture with THP of patient versus THP of control subject.

Results

CF content was significantly higher in patients compared to controls (p < 0.001). Patients had higher levels of modified nucleosides, amino acids, and their derivatives compared to controls. Cytotoxicity for control versus patient mean (SEM) percent was 1.7 (2.9) % versus 63.0 (3.7) %, respectively, (p < 0.001). Cytotoxicity of metabolites was reduced in the presence of THP of control compared to THP of patient (p < 0.001).

Conclusions

Patients with IC had significantly higher levels of cationic metabolites with higher cytotoxicity compared to controls. THP of these patients had reduced ability to sequester cytotoxicity of cationic metabolites. Patients who significantly improved on therapy had the same levels and toxicity of cationic metabolites as symptomatic males, suggesting that these cations may be the cause of epithelial dysfunction in IC.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Parsons CL, Albo M (2002) Intravesical potassium sensitivity in patients with prostatitis. J Urol 168:1054–1057

    Article  PubMed  Google Scholar 

  2. Hassan AA, Elgamal SA, Sabaa MA et al (2007) Evaluation of intravesical potassium sensitivity test and bladder biopsy in patients with chronic prostatitis/chronic pelvic pain syndrome. Int J Urol 14:738–742

    Article  PubMed  Google Scholar 

  3. Parsons CL (2011) The role of a leaky epithelium and potassium in the generation of bladder symptoms in interstitial cystitis/overactive bladder, urethral syndrome, prostatitis and gynaecological chronic pelvic pain. BJU Int 107:370–375. doi:10.1111/j.1464-410X.2010.09843.x

    Article  PubMed  Google Scholar 

  4. Parsons CL, Boychuk D, Jones S et al (1990) Bladder surface glycosaminoglycans: an epithelial permeability barrier. J Urol 143:139–142

    CAS  PubMed  Google Scholar 

  5. Lilly JD, Parsons CL (1990) Bladder surface glycosaminoglycans is a human epithelial permeability barrier. Surg Gynecol Obstet 171:493–496

    CAS  PubMed  Google Scholar 

  6. Parsons CL, Lilly JD, Stein P (1991) Epithelial dysfunction in nonbacterial cystitis (interstitial cystitis). J Urol 145:732–735

    CAS  PubMed  Google Scholar 

  7. Parsons CL, Greenberger M, Gabal L et al (1998) The role of urinary potassium in the pathogenesis and diagnosis of interstitial cystitis. J Urol 159:1862–1866 (discussion 1866–1867)

    Article  CAS  PubMed  Google Scholar 

  8. Parsons CL, Stein PC, Bidair M et al (1994) Abnormal sensitivity to intravesical potassium in interstitial cystitis and radiation cystitis. Neurourol Urodyn 13:515–520

    Article  CAS  PubMed  Google Scholar 

  9. Parsons CL, Shaw T, Berecz Z et al (2014) Role of urinary cations in the aetiology of bladder symptoms and interstitial cystitis. BJU Int 114:286–293. doi:10.1111/bju.12603

    Article  CAS  PubMed  Google Scholar 

  10. Friedlander JI, Shorter B, Moldwin RM (2012) Diet and its role in interstitial cystitis/bladder pain syndrome (IC/BPS) and comorbid conditions. BJU Int 109:1584–1591. doi:10.1111/j.1464-410X.2011.10860.x

    Article  PubMed  Google Scholar 

  11. Erickson DR (2001) Urine markers of interstitial cystitis. Urology 57:15–21

    Article  CAS  PubMed  Google Scholar 

  12. Erickson DR, Tomaszewski JE, Kunselman AR et al (2008) Urine markers do not predict biopsy findings or presence of bladder ulcers in interstitial cystitis/painful bladder syndrome. J Urol 179:1850–1856. doi:10.1016/j.juro.2008.01.047

    Article  PubMed  PubMed Central  Google Scholar 

  13. Kushner L, Chiu PY, Brettschneider N et al (2001) Urinary substance P concentration correlates with urinary frequency and urgency in interstitial cystitis patients treated with intravesical dimethyl sulfoxide and not intravesical anesthetic cocktail. Urology 57:129

    Article  CAS  PubMed  Google Scholar 

  14. Keay S, Zhang CO, Trifillis AL et al (1996) Decreased 3H-thymidine incorporation by human bladder epithelial cells following exposure to urine from interstitial cystitis patients. J Urol 156:2073–2078

    Article  CAS  PubMed  Google Scholar 

  15. Keay S, Reeder JE, Koch K et al (2007) Prospective evaluation of candidate urine and cell markers in patients with interstitial cystitis enrolled in a randomized clinical trial of Bacillus Calmette Guerin (BCG). World J Urol 25:499–504

    Article  PubMed  Google Scholar 

  16. Parsons CL, Bautista SL, Stein PC et al (2000) Cyto-injury factors in urine: a possible mechanism for the development of interstitial cystitis. J Urol 164:1381–1384

    Article  CAS  PubMed  Google Scholar 

  17. Parsons CL, Rajasekaran M, Arsanjani AH et al (2007) Role of sialic acid in urinary cytoprotective activity of Tamm-Horsfall protein. Urology 69:577–581

    Article  PubMed  Google Scholar 

  18. Stein P, Rajasekaran M, Parsons CL (2005) Tamm-Horsfall protein protects urothelial permeability barrier. Urology 66:903–907

    Article  PubMed  Google Scholar 

  19. Rajasekaran M, Stein P, Parsons CL (2006) Toxic factors in human urine that injure urothelium. Int J Urol 13:409–414

    Article  CAS  PubMed  Google Scholar 

  20. Argade SP, Vanichsarn C, Chenoweth M et al (2009) Abnormal glycosylation of Tamm Horsfall Protein in patients with interstitial cystitis. BJU Int 103:1085–1089. doi:10.1111/j.1464-410X.2008.08163.x

    Article  CAS  PubMed  Google Scholar 

  21. Parsons CL, Dell J, Stanford EJ et al (2002) Increased prevalence of interstitial cystitis: previously unrecognized urologic and gynecologic cases identified using a new symptom questionnaire and intravesical potassium sensitivity. Urology 60:573–578

    Article  PubMed  Google Scholar 

  22. Gillenwater JY, Wein AJ (1988) Summary of the National Institute of Arthritis, Diabetes, Digestive and Kidney Diseases Workshop on Interstitial Cystitis, National Institutes of Health, Bethesda, Maryland, August 28–29, 1987. J Urol 140:203–206

    CAS  PubMed  Google Scholar 

  23. Gutsche B, Grun C, Scheutzow D et al (1999) Tryptophan glycoconjugates in food and human urine. Biochem J 343:11–19

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Parsons CL, Benson G, Childs SJ et al (1993) A quantitatively controlled method to study prospectively interstitial cystitis and demonstrate the efficacy of pentosanpolysulfate. J Urol 150:845–848

    CAS  PubMed  Google Scholar 

  25. Gillespie L (1993) Metabolic appraisal of the effects of dietary modification on hypersensitive bladder symptoms. Br J Urol 72:293–297

    Article  CAS  PubMed  Google Scholar 

  26. Kaufman JE, Anderson K, Parsons CL (1987) Inactivation of antiadherence effect of bladder surface glycosaminoglycans as possible mechanism for carcinogenesis. Urology 30:255–258

    Article  CAS  PubMed  Google Scholar 

  27. Akiyama A, Stein PC, Houshiar A et al (2000) Urothelial cytoprotective activity of Tamm-Horsfall protein isolated from the urine of healthy subjects and patients with interstitial cystitis. Int J Urol 7:176–183

    Article  CAS  PubMed  Google Scholar 

  28. Parsons CL, Proctor J, Teichman JS et al (2011) A multi-site study confirms abnormal glycosylation in the Tamm-Horsfall protein of patients with interstitial cystitis. J Urol 186:112–116. doi:10.1016/j.juro.2011.02.2699

    Article  CAS  PubMed  Google Scholar 

  29. Parsons CL, Stein P, Zupkas P et al (2007) Defective Tamm-Horsfall protein in patients with interstitial cystitis. J Urol 178:2665–2670

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to C. Lowell Parsons.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Argade, S., Berecz, Z., Su, Y. et al. Increased toxic urinary cations in males with interstitial cystitis: a possible cause of bladder symptoms. World J Urol 34, 1685–1691 (2016). https://doi.org/10.1007/s00345-016-1808-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00345-016-1808-4

Keywords

Navigation